5 Results for "

NLRC3

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "NLRC3" in MCE Product Catalog:

Cat. No.: HY-N0921
CAS No.: 19902-91-1
Synonyms: (+)-Dihydromethysticin
Dihydromethysticin is an orally active natural active ingredient. Dihydromethysticin can be extracted from Piper methysticum. Dihydromethysticin inhibits carboxylesterase 1 (Ki = 68.2 μM) and CYP2A5. Dihydromethysticin upregulates NLRC3 and induces Apoptosis. Dihydromethysticin exhibits anticancer activity against colorectal cancer and lung adenoma [3] .
loading...
    loading...
Cat. No.: HY-RS09346
Research Areas:  

Others

NLRC3 Human Pre-designed siRNA Set A contains three designed siRNAs for NLRC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS26570
Research Areas:  

Others

Nlrc3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nlrc3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS20066
Research Areas:  

Others

Nlrc3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nlrc3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-N0921R
CAS No.: 19902-91-1
Synonyms: (+)-Dihydromethysticin (Standard)
Dihydromethysticin (Standard) is the analytical standard of Dihydromethysticin (HY-N0921). This product is intended for research and analytical applications. Dihydromethysticin is an orally active natural active ingredient. Dihydromethysticin can be extracted from Piper methysticum. Dihydromethysticin inhibits carboxylesterase 1 (Ki = 68.2 μM) and CYP2A5. Dihydromethysticin upregulates NLRC3 and induces Apoptosis. Dihydromethysticin exhibits anticancer activity against colorectal cancer and lung adenoma [3] .
loading...
    loading...